Current Issue

Sponsored
Keywords

Biomarkers - Related Content

Feature Articles: Biomarkers Take Center Stage
Find out what new research is being done with biomarkers in this article from our May 1 issue.
Corporate Profiles: Cytomics for Personalized Heart Health
CytoVas’ Vascular Profile Uses Biomarkers to Test Patients’ Cardiovascular Status
BioMarket Trends: Exosome Research Publication Landscape
Examining Current Market Trends and Segments of Research Efforts
BioPerspectives: Personalized Medicine: From Biomarkers to Companion Diagnostics
This third chapter of a five-part series talks about coordinating diagnostic test kit development between pharmaceutical companies and diagnostic manufacturers.
BioPerspectives: New Biomarkers Could Offer Vital Clues for Cancer Research
European funding for cancer research has led to some interesting results in recent years.

Literature Review: ELISA—Detected Through A Quick Glance
February 7, 2013
Researchers provide an assay chemistry that allows for a direct visual scoring of an ELISA result to detect protein analytes at ultralow concentrations.
DNA Methylation Rules: Studying Epigenetics with New Tools
February 7, 2013
The tools to unravel the epigenetic control mechanisms that influence how cells control access of transcriptional proteins to DNA are just beginning to emerge.
The Search for Depression Biomarkers
August 27, 2012
The ability to predict drug responses more accurately is driving efforts.
Blood Flow as Diagnostic Marker
August 17, 2012
Jamming, or vaso-occlusion, could be used to distinguish sickle cell disease patients with poor outcomes from those with good outcomes.
Why Biomarker Discovery Is Hard
June 25, 2012
Differentiating which markers are in the driver’s seat and which are along for the ride is key.

FIRST USE OF NANOSENSORS TO MEASURE CANCER BIOMARKERS IN BLOOD
- Interview with Mark Reed, Ph.D., Harold Hodgkinson Chair of Engineering and Applied Science, Yale University, and Associate Director of the Yale Institute for Nanoscience and Quantum Engineering
NOVEL BIOMARKER FOR AGE-RELATED MACULAR DEGENERATION
- Interview with Jayakrishna Ambati, M.D., Professor of Physiology and Professor and Vice Chair of Ophthalmology and Visual Sciences, University of Kentucky
miRNA BIOMARKERS FOR DRUG-INDUCED LIVER INJURY
- Interview with David Galas, Ph.D., Senior Vice President of Strategic Partnerships, Institute for Systems Biology

	Singulex Heterodimer Immunoassay Kit The Erenna® Interleuken-17A/F (IL-17A/F) heterodimer immunoassay kit is an addition to a suite of TH17 pathway bioassays which also includes IL-17A and IL-17F as well as several others. These biomarkers are members of the IL-17 signaling pathw
	Randox Laboratories Tumor Marker Control The Acusera multianalyte liquid tumor marker control covers a total of 15 commonly tested and esoteric cancer antigens and tumor markers. Assayed target values can help laboratories monitor both accuracy and precision. The liquid stable nature redu
	Olink Bioscience Protein Biomarker Immunoassays Proseek® Multiplex is a generation of multiplexed protein biomarker immunoassays based on the Proximity Extension Assay (PEA) platform. Proseek Multiplex allows biomarker researchers to quantify 92 proteins in one microliter sample against a p
	Horizon Discovery DNA Reference Standard The Quantitative Multiplex DNA reference standard is intended for researchers assessing multiple biomarkers in a single assay using platforms such as next-generation sequencing. It can enable researchers to quantify a range of detection thresholds